Intensity Therapeutics Statistics
Total Valuation
INTS has a market cap or net worth of $65.14 million. The enterprise value is $54.77 million.
| Market Cap | 65.14M |
| Enterprise Value | 54.77M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
INTS has 13.71 million shares outstanding. The number of shares has increased by 302.03% in one year.
| Shares Outstanding | 13.71M |
| Shares Change (YoY) | +302.03% |
| Shares Change (QoQ) | +59.11% |
| Owned by Insiders (%) | 47.37% |
| Owned by Institutions (%) | 11.90% |
| Float | 6.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.70 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.43, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.43 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -61.29 |
Financial Efficiency
Return on equity (ROE) is -112.20% and return on invested capital (ROIC) is -119.84%.
| Return on Equity (ROE) | -112.20% |
| Return on Assets (ROA) | -93.50% |
| Return on Capital (ROIC) | -119.84% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.16M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.13% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -26.13% |
| 50-Day Moving Average | 4.81 |
| 200-Day Moving Average | 4.53 |
| Relative Strength Index (RSI) | 45.53 |
| Average Volume (20 Days) | 12,722 |
Short Selling Information
The latest short interest is 18,115, so 0.13% of the outstanding shares have been sold short.
| Short Interest | 18,115 |
| Short Previous Month | 32,869 |
| Short % of Shares Out | 0.13% |
| Short % of Float | 0.29% |
| Short Ratio (days to cover) | 1.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.81M |
| Pretax Income | -13.80M |
| Net Income | -15.13M |
| EBITDA | -13.53M |
| EBIT | -13.58M |
| Earnings Per Share (EPS) | -$2.06 |
Balance Sheet
The company has $10.50 million in cash and $131,000 in debt, giving a net cash position of $10.37 million or $0.76 per share.
| Cash & Cash Equivalents | 10.50M |
| Total Debt | 131,000 |
| Net Cash | 10.37M |
| Net Cash Per Share | $0.76 |
| Equity (Book Value) | 9.72M |
| Book Value Per Share | 0.71 |
| Working Capital | 8.65M |
Cash Flow
| Operating Cash Flow | -10.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.67M |
| FCF Per Share | -$0.78 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -302.03% |
| Shareholder Yield | -302.03% |
| Earnings Yield | -23.23% |
| FCF Yield | -16.38% |
Analyst Forecast
The average price target for INTS is $12.00, which is 152.63% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.00 |
| Price Target Difference | 152.63% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |